These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 17180583)
1. Surveillance of antimicrobial use and antimicrobial resistance in German intensive care units (SARI): a summary of the data from 2001 through 2004. Meyer E; Schwab F; Gastmeier P; Rueden H; Daschner FD Infection; 2006 Dec; 34(6):303-9. PubMed ID: 17180583 [TBL] [Abstract][Full Text] [Related]
2. Methicillin-resistant Staphylococcus aureus in German intensive care units during 2000-2003: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in Intensive Care Units). Meyer E; Schwab F; Gastmeier P; Jonas D; Rueden H; Daschner FD Infect Control Hosp Epidemiol; 2006 Feb; 27(2):146-54. PubMed ID: 16465631 [TBL] [Abstract][Full Text] [Related]
3. Dramatic increase of third-generation cephalosporin-resistant E. coli in German intensive care units: secular trends in antibiotic drug use and bacterial resistance, 2001 to 2008. Meyer E; Schwab F; Schroeren-Boersch B; Gastmeier P Crit Care; 2010; 14(3):R113. PubMed ID: 20546564 [TBL] [Abstract][Full Text] [Related]
4. Surveillance of antimicrobial use and antimicrobial resistance in intensive care units (SARI): 1. Antimicrobial use in German intensive care units. Meyer E; Schwab F; Jonas D; Rueden H; Gastmeier P; Daschner FD Intensive Care Med; 2004 Jun; 30(6):1089-96. PubMed ID: 15045167 [TBL] [Abstract][Full Text] [Related]
5. [SARI: surveillance of antibiotic use and bacterial resistance in German intensive care units. Correlation between antibiotic use and the emergence of resistance]. Meyer E; Jonas D; Schwab F; Gastmeier P; Rüden H; Daschner FD Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Apr; 47(4):345-51. PubMed ID: 15205777 [TBL] [Abstract][Full Text] [Related]
6. Temporal changes in bacterial resistance in German intensive care units, 2001-2003: data from the SARI (surveillance of antimicrobial use and antimicrobial resistance in intensive care units) project. Meyer E; Schwab F; Jonas D; Ruden H; Gastmeier P; Daschner FD J Hosp Infect; 2005 Aug; 60(4):348-52. PubMed ID: 15923060 [TBL] [Abstract][Full Text] [Related]
7. Surveillance of Antibiotic Use and Resistance in Intensive Care Units (SARI). Remschmidt C; Schneider S; Meyer E; Schroeren-Boersch B; Gastmeier P; Schwab F Dtsch Arztebl Int; 2017 Dec; 114(50):858-865. PubMed ID: 29271345 [TBL] [Abstract][Full Text] [Related]
8. Design of a surveillance system of antibiotic use and bacterial resistance in German intensive care units (SARI). Meyer E; Jonas D; Schwab F; Rueden H; Gastmeier P; Daschner FD Infection; 2003 Aug; 31(4):208-15. PubMed ID: 14562943 [TBL] [Abstract][Full Text] [Related]
9. Low antibiotic resistance rates in Staphylococcus aureus, Escherichia coli and Klebsiella spp but not in Enterobacter spp and Pseudomonas aeruginosa: a prospective observational study in 14 Swedish ICUs over a 5-year period. Hanberger H; Burman LG; Cars O; Erlandsson M; Gill H; Nilsson LE; Nordlinder D; Walther SM; Acta Anaesthesiol Scand; 2007 Aug; 51(7):937-41. PubMed ID: 17635399 [TBL] [Abstract][Full Text] [Related]
10. Genodiversity of resistant Pseudomonas aeruginosa isolates in relation to antimicrobial usage density and resistance rates in intensive care units. Jonas D; Meyer E; Schwab F; Grundmann H Infect Control Hosp Epidemiol; 2008 Apr; 29(4):350-7. PubMed ID: 18269329 [TBL] [Abstract][Full Text] [Related]
11. Stenotrophomonas maltophilia and antibiotic use in German intensive care units: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in German Intensive Care Units). Meyer E; Schwab F; Gastmeier P; Rueden H; Daschner FD; Jonas D J Hosp Infect; 2006 Nov; 64(3):238-43. PubMed ID: 16979794 [TBL] [Abstract][Full Text] [Related]
12. Relationship between rates of antimicrobial consumption and the incidence of antimicrobial resistance in Staphylococcus aureus and Pseudomonas aeruginosa isolates from 47 French hospitals. Rogues AM; Dumartin C; Amadéo B; Venier AG; Marty N; Parneix P; Gachie JP Infect Control Hosp Epidemiol; 2007 Dec; 28(12):1389-95. PubMed ID: 17994520 [TBL] [Abstract][Full Text] [Related]
13. [Quality assurance in intensive care medicine. SARI-surveillance on antibiotic use and bacterial resistance in intensive care units]. Meyer E; Schroeren-Boersch B; Schwab F; Jonas D; Rüden H; Gastmeier P; Daschner FD Anaesthesist; 2004 May; 53(5):427-33. PubMed ID: 15004690 [TBL] [Abstract][Full Text] [Related]
14. Effects of long-term routine use of selective digestive decontamination on antimicrobial resistance. Heininger A; Meyer E; Schwab F; Marschal M; Unertl K; Krueger WA Intensive Care Med; 2006 Oct; 32(10):1569-76. PubMed ID: 16896852 [TBL] [Abstract][Full Text] [Related]
15. Antibiotic consumption and resistance: data from Europe and Germany. Meyer E; Gastmeier P; Deja M; Schwab F Int J Med Microbiol; 2013 Aug; 303(6-7):388-95. PubMed ID: 23727396 [TBL] [Abstract][Full Text] [Related]
16. Antimicrobial susceptibility patterns in Pseudomonas aeruginosa: data from a multicenter Intensive Care Unit Surveillance Study (ISS) in the United States. Friedland I; Gallagher G; King T; Woods GL J Chemother; 2004 Oct; 16(5):437-41. PubMed ID: 15565908 [TBL] [Abstract][Full Text] [Related]
17. [Surveillance of antibiotic use and bacterial resistance in intensive care units]. Meyer E; Schwab F; Schroeren-Boersch B; Gastmeier P Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Aug; 51(8):926-35. PubMed ID: 18787871 [TBL] [Abstract][Full Text] [Related]
18. Influence of regular reporting on local Pseudomonas aeruginosa and Acinetobacter spp. sensitivity to antibiotics on consumption of antibiotics and resistance patterns. Djordjevic ZM; Folic MM; Jankovic SM J Clin Pharm Ther; 2017 Oct; 42(5):585-590. PubMed ID: 28556289 [TBL] [Abstract][Full Text] [Related]
19. Regional trends in multidrug-resistant infections in German intensive care units: a real-time model for epidemiological monitoring and analysis. Kohlenberg A; Schwab F; Meyer E; Behnke M; Geffers C; Gastmeier P J Hosp Infect; 2009 Nov; 73(3):239-45. PubMed ID: 19804919 [TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa is not just in the intensive care unit any more: implications for empirical therapy. Eagye KJ; Banevicius MA; Nicolau DP Crit Care Med; 2012 Apr; 40(4):1329-32. PubMed ID: 22425824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]